ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Biologics and DMARDs"

  • Abstract Number: 1805 • 2019 ACR/ARP Annual Meeting

    Perioperative Anti-rheumatic Medications Are Not Associated with 30-day Odds of Infection in Rheumatoid Arthritis Patients Undergoing Surgery: A Retrospective Cohort Study

    Marianne Kerski1, Peter Boersma 2, Eric Miller 3, Ashley Brenner 4, Genevieve Melton 5 and Anna Shmagel 6, 1University of Minnesota Medical School, Minneapolis, MN, 2University of Minnesota School of Public Health, Minneapolis, 3University of Minnesota, Woodbury, MN, 4University of Minnesota Best Practices Integrated Informatics Core (BPIC), Minneapolis, MN, 5University of Minnesota Department of Surgery, Minneapolis, MN, 6University of Minnesota, Minneapolis, MN

    Background/Purpose: Perioperative management of anti-rheumatic drugs in rheumatoid arthritis (RA) patients undergoing surgery remains controversial. Previous studies produced conflicting results, and data on non-orthopedic surgeries…
  • Abstract Number: 2343 • 2019 ACR/ARP Annual Meeting

    Treatment with Biologic DMARDs Does Not Increase Risk of Severe Pulmonary Events in Patients with Rheumatoid Arthritis and Pre-existing Lung Disease

    Shinji Watanabe1, Takahisa Gono 1, Ryosuke Fukue 1, Seiji Kobayashi 1, Yuichiro Shirai 2, Mitsuhiro Takeno 3 and Masataka Kuwana 2, 1Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, Tokyo, Japan, 2Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, Bunkyo-ku, Tokyo, Japan, 3Nippon Medical School, Tokyo, Japan

    Background/Purpose: Pulmonary complication is one of the leading causes of mortality in patients with rheumatoid arthritis (RA). Pre-existing lung disease is known as a risk…
  • Abstract Number: 2908 • 2019 ACR/ARP Annual Meeting

    Remission in Patients with Rheumatoid Arthritis Receiving Triple Therapy Compared to Biological Therapy – A Swedish Nationwide Register Study

    Hanna Källmark1, Jon Einarsson 2, Jan-Åke Nilsson 3 and Meliha Kapetanovic 2, 1Lund University, Lund, Sweden, 2Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Section of Rheumatology, Lund and Malmö, Sweden, Lund, Sweden, 3Skane University Hospital, Lund and Malmö, Sweden, Lund, Sweden

    Background/Purpose: Current treatment guidelines for rheumatoid arthritis (RA) recommend a treat-to-target approach with early treatment initiation of disease-modifying antirheumatic drugs (DMARDs), most commonly methotrexate (MTX),…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences